Ame Company For Medical Supplies
TADAWUL:9527.SR
93 (SAR) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SAR.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Assets: | |||||
| Current Assets: | |||||
| Cash & Cash Equivalents
| 43.403 | 23.321 | 28.417 | 14.7 | 7.931 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 43.403 | 23.321 | 28.417 | 14.7 | 7.931 |
| Net Receivables
| 89.807 | 82.102 | 74.052 | 59.146 | 48.758 |
| Inventory
| 50.357 | 43.488 | 25.089 | 23.737 | 26.238 |
| Other Current Assets
| 0.384 | 2.9 | 3.302 | 2.529 | 1.003 |
| Total Current Assets
| 183.951 | 151.811 | 130.86 | 100.11 | 83.93 |
| Non-Current Assets: | |||||
| Property, Plant & Equipment, Net
| 4.74 | 2.199 | 2.238 | 0.784 | 0.771 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 1.529 | 0.353 | 0.79 | 1.614 | 1.295 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets
| 6.269 | 2.552 | 3.029 | 2.399 | 2.066 |
| Total Assets
| 190.219 | 154.362 | 133.888 | 102.509 | 85.996 |
| Liabilities & Equity: | |||||
| Current Liabilities: | |||||
| Account Payables
| 0.511 | -0.983 | 0.247 | 0.002 | 5.855 |
| Short Term Debt
| 1.202 | 0.394 | 0.382 | 4.676 | 0.168 |
| Tax Payables
| 7.552 | 5.391 | 3.881 | 2.105 | 3.218 |
| Deferred Revenue
| 1.267 | 0.983 | 26.365 | 0.479 | 0.464 |
| Other Current Liabilities
| 49.181 | 37.034 | 4.914 | 29.465 | 58.173 |
| Total Current Liabilities
| 52.162 | 37.429 | 31.907 | 34.622 | 64.659 |
| Non-Current Liabilities: | |||||
| Long Term Debt
| 1.396 | 0.708 | 1.122 | 0 | 0 |
| Deferred Revenue Non-Current
| 0.243 | 0.267 | 0.37 | 0.25 | 0.185 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 9.249 | 8.609 | 7.075 | 4.089 | 2.907 |
| Total Non-Current Liabilities
| 10.888 | 9.584 | 8.566 | 4.339 | 3.092 |
| Total Liabilities
| 63.05 | 47.013 | 40.474 | 38.961 | 67.751 |
| Equity: | |||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 70 | 70 | 70 | 0.5 | 0.5 |
| Retained Earnings
| 52.129 | 32.309 | 21.042 | 62.798 | 17.495 |
| Accumulated Other Comprehensive Income/Loss
| 5.041 | 5.041 | 2.372 | 0.25 | 0.25 |
| Other Total Stockholders Equity
| 0 | 0 | 0 | 0 | 0 |
| Total Shareholders Equity
| 127.169 | 107.35 | 93.414 | 63.548 | 18.245 |
| Total Equity
| 127.169 | 107.35 | 93.414 | 63.548 | 18.245 |
| Total Liabilities & Shareholders Equity
| 190.219 | 154.362 | 133.888 | 102.509 | 85.996 |